Thalidomide: The Tragedy of Birth Defects and the Effective Treatment of Disease

Shedding light on an old mystery: Thalidomide suppresses survival pathways to induce limb defects

(2011) Jürgen Knobloch et al.   CELL CYCLE

Genetic Factors Underlying the Risk of Thalidomide-Related Neuropathy in Patients With Multiple Myeloma

(2011) David C. Johnson et al.   JOURNAL OF CLINICAL ONCOLOGY

Identification of a Primary Target of Thalidomide Teratogenicity

(2010) T. Ito et al.   SCIENCE

Thalidomide and misoprostol: Ophthalmologic manifestations and associations both expected and unexpected

(2009) Marilyn T. Miller et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation

(2009) C. Therapontos et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A retrospective analysis of developmental toxicity studies in rat and rabbit: What is the added value of the rabbit as an additional test species?

(2007) Gemma Janer et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY